Dr. Vogl discusses the role of genetic testing for prostate cancer

This EAU podcast has been developed with financial support from Pfizer Inc for healthcare professionals based in the EU and UK. The content discussed here was up to date at the time of recording in June 2024 and may not be suitable in your local market. The EAU has retained full editorial control.In this episode, the panel chair of the EAU guidelines on prostate cancer, Prof. Philip Cornford (GB) is at UROonco24 in Budapest, and talks to medical oncologist Dr. Ursula Vogl (CH) on the role of genetic testing for prostate cancer.Dr. Vogl discusses why genetic testing is important, and defines both somatic (tissue) testing, and germline testing. She shares her opinion on why ideally both should be done, and when, as well as an explanation of the guidelines.To keep updated on prostate cancer developments, go to the UROONCO Prostate Cancer Educational Platform. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.PP-UNP-GBR-10244.  September 2024